» Articles » PMID: 36340031

Ubiquitin Modification in Osteogenic Differentiation and Bone Formation: From Mechanisms to Clinical Significance

Overview
Specialty Cell Biology
Date 2022 Nov 7
PMID 36340031
Authors
Affiliations
Soon will be listed here.
Abstract

The ubiquitin-proteasome system is an important pathway for mediating posttranslational modification and protein homeostasis and exerts a wide range of functions in diverse biological processes, including stem cell differentiation, DNA repair, and cell cycle regulation. Many studies have shown that ubiquitination modification plays a critical role in regulating the osteogenic differentiation of stem cells and bone formation through various mechanisms. This review summarizes current progress on the effects and mechanisms of ubiquitin modification on transcription factors and signaling pathways involved in osteogenic differentiation. Moreover, the review highlights the latest advances in the clinical application of drugs in bone tissue engineering. A thorough understanding of ubiquitin modifications may provide promising therapeutic targets for stem cell-based bone tissue engineering.

Citing Articles

The role of WWP1 and WWP2 in bone/cartilage development and diseases.

Wang Y, Wu Z, Wang C, Wu N, Wang C, Hu S Mol Cell Biochem. 2024; 479(11):2907-2919.

PMID: 38252355 DOI: 10.1007/s11010-023-04917-7.


The promotive role of USP1 inhibition in coordinating osteogenic differentiation and fracture healing during nonunion.

Huang J, Zhou H, He L, Zhong L, Zhou D, Yin Z J Orthop Surg Res. 2023; 18(1):152.

PMID: 36859264 PMC: 9979441. DOI: 10.1186/s13018-023-03594-y.

References
1.
Herhaus L, Al-Salihi M, Macartney T, Weidlich S, Sapkota G . OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3. Nat Commun. 2013; 4:2519. PMC: 3791481. DOI: 10.1038/ncomms3519. View

2.
Liu J, Li X, Zhang H, Gu R, Wang Z, Gao Z . Ubiquitin E3 ligase Itch negatively regulates osteoblast function by promoting proteasome degradation of osteogenic proteins. Bone Joint Res. 2017; 6(3):154-161. PMC: 5376659. DOI: 10.1302/2046-3758.63.BJR-2016-0237.R1. View

3.
Mukherjee S, Raje N, Schoonmaker J, Liu J, Hideshima T, Wein M . Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice. J Clin Invest. 2008; 118(2):491-504. PMC: 2213372. DOI: 10.1172/JCI33102. View

4.
Suresh B, Lee J, Kim H, Ramakrishna S . Regulation of pluripotency and differentiation by deubiquitinating enzymes. Cell Death Differ. 2016; 23(8):1257-64. PMC: 4947674. DOI: 10.1038/cdd.2016.53. View

5.
Yun S, Kim H, Yoon J, Park W, Hahn M, Kim H . Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer. Mol Oncol. 2015; 9(9):1834-51. PMC: 5528720. DOI: 10.1016/j.molonc.2015.06.006. View